EBS Emergent BioSolutions Inc.

NYSE emergentbiosolutions.com


$ 9.40 $ -0.20 (-2.08 %)    

Thursday, 16-Oct-2025 19:51:32 EDT
QQQ $ 593.26 $ 0.00 (0 %)
DIA $ 456.09 $ 0.00 (0 %)
SPY $ 654.51 $ 0.00 (0 %)
TLT $ 91.46 $ 0.00 (0 %)
GLD $ 399.36 $ 0.00 (0 %)
$ 9.4
$ 9.66
$ 9.10 x 77
$ 10.01 x 10
-- - --
$ 4.02 - $ 12.73
961,915
na
501.5M
$ 1.69
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-03-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 03-08-2024 12-31-2023 10-K
8 12-11-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-01-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-01-2022 06-30-2022 10-Q
14 04-28-2022 03-31-2022 10-Q
15 02-25-2022 12-31-2021 10-K
16 11-05-2021 09-30-2021 10-Q
17 07-30-2021 06-30-2021 10-Q
18 04-30-2021 03-31-2021 10-Q
19 02-19-2021 12-31-2020 10-K
20 11-06-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-01-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-02-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 02-22-2019 12-31-2018 10-K
28 11-02-2018 09-30-2018 10-Q
29 08-03-2018 06-30-2018 10-Q
30 05-04-2018 03-31-2018 10-Q
31 02-23-2018 12-31-2017 10-K
32 11-03-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-05-2017 03-31-2017 10-Q
35 02-28-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-05-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-emergent-biosolutions-maintains-15-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Emergent BioSolutions (NYSE:EBS) with a Buy and maintains $15 ...

 emergent-biosolutions-secures-30m-barda-contract-to-supply-cyfendus-anthrax-vaccine-by-march-2026

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has received a $30 million contract modification from the Biomedical A...

 emergent-biosolutions-files-for-mixed-shelf-of-up-to-250m

 -SEC Filing

 emergent-biosolutions-narrows-fy2025-sales-guidance-from-75000m-85000m-to-76500m-83500m-vs-80000m-est

Emergent BioSolutions (NYSE:EBS) narrows FY2025 sales outlook from $750.00 million-$850.00 million to $765.00 million-$835.00 m...

 emergent-biosolutions-q2-adj-eps-016-beats-072-estimate-sales-14090m-beat-10500m-estimate

Emergent BioSolutions (NYSE:EBS) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $(...

 emergent-biosolutions-publishes-comprehensive-review-on-brincidofovir-for-mpox-in-expert-review-of-anti-infective-therapy-journal

Emergent BioSolutions Inc. (NYSE:EBS) today announced the publication of a comprehensive review article, "Brincidofovir in ...

 emergent-biosolutions-applauds-us-house-for-adding-otc-naloxone-to-aed-locations-to-combat-opioid-overdose-deaths

Emergent BioSolutions Inc. (NYSE:EBS) today announces its recognition of the U.S. House of Representatives for adding over-the-...

 emergent-biosolutions-wins-519m-contract-modification-award-for-cnj-016-vaccinia-immune-globulin-intravenous-human-as-part-oo-us-biodefense-preparedness-efforts

GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced a contract modificat...

 emergent-biosolutions-expands-its-proprietary-narcan-direct-online-distribution-network-to-include-kloxxado-nasal-spray-8-mg

GAITHERSBURG, Md., July 02, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the expansion of its...

 emergent-biosolutions-bags-624m-contract-modification-from-united-states-department-of-hhs-aspr-for-bat

Emergent BioSolutions Inc. (NYSE:EBS) today announced it has been awarded a $62.4 million contract modification from the Admini...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION